Endocannabinoid
Resource Center
TOP ARTICLES

Mayo Clinicians’ Guide to Cannabidiol and Hemp Oil
In this summary-scientific review from Mayo Clinical Proceedings, the researchers provide an overview of the scientific work on cannabidiol and hemp oil and the distinction between marijuana, hemp, and the different components of CBD and hemp oil products. They summarize the current legal status of CBD and hemp oils in

Webinar: The Most Common Therapeutic Applications of CBD
Do you have questions about the therapeutic applications of CBD? We thought so. Preclinical and clinical studies suggest that cannabidiol (CBD) has broad therapeutic value. With emerging knowledge and a lack of education about the Endocannabinoid System (ECS) in most medical schools, the vast majority of health professionals have limited

FDA Announces Early Fall Cannabidiol Hearings and Clarifies Commitment to Enforcement
The FDA announced that it will host further cannabidiol hearing on the regulatory structure of CBD products in the early fall. The news was embedded in a press release regarding a warning issued to a CBD maker CuraLeaf for making unfounded claims to treat cancer, Alzheimer’s disease, opioid withdrawal, pain

Medicinal Cannabis Reduces or Ends Seizures in Children with Severe, Drug-resistant Epilepsy
Medicinal cannabis oil containing both cannabidiol (CBD) and a small amount of THC can reduce or end seizures in children with severe, drug-resistant epilepsy, a study by the University of Saskatchewan (USask), Canada has found. Children with severe drug-resistant epilepsy also experienced improvements in their quality of life after taking

Could the Endocannabinoid System Offer a New Treatment Target for Obsessive Compulsive Disorder?
The disabling condition of obsessive-compulsive disorder (OCD) affects about 2–3% of people worldwide. Evidence suggests that abnormalities in cortico-striatal-thalamic-cortical circuitry and specific gene variants contribute to the pathogenesis of the disorder. This latest study, published in Cannabis and Cannabinoid Research, suggests that the endocannabinoid system (ECS) plays a role in OCD symptoms

International Cannabinoid Research Society (ICRS) Names Cannabis and Cannabinoid Research Its Official Journal
New Rochelle, NY, May 7, 2019—Cannabis and Cannabinoid Research (CCR) is extremely excited to announce that the International Cannabinoid Research Society (ICRS) has named CCR its Official Journal. The ICRS is a foremost international society spearheading scientific research in all fields of cannabinoids, ranging from biochemical, chemical, and physiological studies

Four Articles: Cannabis and Cannabinoid Use in Palliative Care, Open Access until May 6, 2019
Patients are aware that medical cannabis and cannabinoid derivatives are available to treat pain and symptoms. However, the medical literature to guide palliative medicine physicians in recommending cannabis and cannabinoid use is not yet well developed. The Journal of Palliative Care, David Casarett, MD, Guest Editor and Chief of Palliative Care